Literature DB >> 18755703

How should we optimize cardiac resynchronization therapy?

Tony Stanton1, Nathaniel M Hawkins, Kerry J Hogg, Nicholas E R Goodfield, Mark C Petrie, John J V McMurray.   

Abstract

Optimization of cardiac resynchronization therapy is increasingly performed. Numerous methods have been proposed, many being echocardiographic. Both the technique and the timing of optimization are contentious. Whether acute haemodynamic benefits translate into long-term improvements in remodelling, symptoms, or prognosis is unknown. Recent guidelines from the American Society of Echocardiography advocate routine optimization. Here, we objectively review the principles, methods, timing, and evidence supporting optimization. Despite limited validation, optimization was included in landmark clinical trials and is inherent in evidence-based practice. Randomized controlled trials comparing methods are needed, with long-term clinical endpoints. For now, optimization should be performed using the iterative method, according to the CARE-HF protocol.

Mesh:

Year:  2008        PMID: 18755703     DOI: 10.1093/eurheartj/ehn380

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Effect of periodic pacemaker optimization on left atrial reverse remodeling in long-term cardiac resynchronization therapy.

Authors:  Guangwei Pan; Zhiqiang Liu; Pengyi He; Yuchun Yang; Yuming Mu; Wei Han; Muhuyati Wulasihan
Journal:  J Interv Card Electrophysiol       Date:  2013-10-23       Impact factor: 1.900

2.  Echocardiography versus intracardiac electrocardiography-based optimization for cardiac resynchronization therapy : a comparative clinical long-term trial.

Authors:  C J Jensen; A Liadski; M Bell; C K Naber; O Bruder; G V Sabin; B Küpper; H Wieneke
Journal:  Herz       Date:  2011-10       Impact factor: 1.443

Review 3.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 4.  Strategies for pacemaker programming in acute heart failure.

Authors:  Marc K Lahiri; Justin T Mao; Claudio D Schuger
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

5.  Recent advances in the application of computational mechanics to the diagnosis and treatment of cardiovascular disease.

Authors:  Juan C Del Alamo; Alison L Marsden; Juan C Lasheras
Journal:  Rev Esp Cardiol       Date:  2009-07       Impact factor: 4.753

Review 6.  Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent developments.

Authors:  Geert E Leenders; Maarten J Cramer; Margot D Bogaard; Mathias Meine; Pieter A Doevendans; Bart W De Boeck
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 7.  Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.

Authors:  Patrick Houthuizen; Frank A L E Bracke; Berry M van Gelder
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

8.  Pre-ejection period by radial artery tonometry supplements echo Doppler findings during biventricular pacemaker optimization.

Authors:  Nima Taha; Jing Zhang; Reza Rafie; Rupesh Ranjan; Salima Qamruddin; Tasneem Z Naqvi
Journal:  Cardiovasc Ultrasound       Date:  2011-07-28       Impact factor: 2.062

9.  Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy.

Authors:  Bozena Urbanek; Krzysztof Kaczmarek; Artur Klimczak; Jan Ruta; Michal Chudzik; Katarzyna Piestrzeniewicz; Pawel Ptaszynski; Jerzy Krzysztof Wranicz
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

10.  Predictive factors and clinical effect of optimized cardiac resynchronization therapy.

Authors:  Guo-Jun Xu; Tian-Yi Gan; Bao-Peng Tang; Yi-Tong Ma; Yu Zhang; Jin-Xin Li; Yan-Yi Zhang; Jiang Wang; Qi Tang; Chun-Mei Wang; Yao-Dong Li; Jiang-Hua Zhang
Journal:  Exp Ther Med       Date:  2012-06-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.